Parnax Lab Limited (BOM:506128)

India flag India · Delayed Price · Currency is INR
162.10
-2.90 (-1.76%)
At close: Apr 28, 2026
65.07%
Market Cap 1.89B
Revenue (ttm) 2.28B
Net Income (ttm) 125.20M
Shares Out 11.49M
EPS (ttm) 10.90
PE Ratio 15.13
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,463
Average Volume 7,352
Open 165.00
Previous Close 165.00
Day's Range 160.00 - 169.00
52-Week Range 85.60 - 167.00
Beta 0.01
RSI 67.91
Earnings Date May 29, 2026

About Parnax Lab

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provid... [Read more]

Industry Pharmaceutical Preparations
Founded 1982
Employees 12
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506128
Full Company Profile

Financial Performance

In fiscal year 2025, Parnax Lab's revenue was 1.88 billion, a decrease of -0.54% compared to the previous year's 1.89 billion. Earnings were 115.19 million, an increase of 19.87%.

Financial Statements

News

There is no news available yet.